Skip to main content
Quest Diagnostics Home
Call
Menu

Quest Diagnostics is bringing a new perspective to this year's American Society of Reproductive Medicine (ASRM) Scientific Congress. Stop by booth #1453, or schedule an appointment with our team using the link below to discover how our unified reproductive health solutions help strengthen your care models and support patients every step of the way.

Let's meet at ASRM

  • See how our integrated lab solutions deliver a complete fertility testing solution
  • Learn how we work with practices to help reduce complexity and save time
  • Explore ways we can help you enhance patient trust and experience across the fertility journey
Schedule an appointment with a member of our team at ASRM

Aligning diagnostics to every protocol and patient path

Our broad, patient-aligned solutions support individualized care planning and flex to match the timing, complexity, and sequencing of each patient journey, whether you're identifying the cause of infertility or managing pregnancy outcomes.

 

Broad portfolio of clinically relevant, right-sized solutions for patients

QHerit® carrier screening

 

Carrier screening is an essential part of preconception and fertility care, helping identify potential genetic risks before treatment begins. QHerit offers 5 panel options and screens for up to 611 conditions so you can match the appropriate level of screening to each patient's unique journey. 

 

By providing clear, actionable insights, we support you in counseling patients with confidence, improving reproductive decision-making, and helping families move forward with clarity.

Learn more
Cheerful doctor talking with his patient in doctors office at hospital.

SIMPLIFYING DONOR SCREENING WITH PRECISION AND SPEED

Reproductive donor screening

As part of our specialized fertility solutions, our reproductive donor testing delivers the speed, convenience, and accuracy you need, without the complexity. With an extensive menu for both male and female donors and a simplified ordering process through your EMR and/or Quanum Lab Services Manager, we aim to make the process easier. 
 

In addition, our dedicated customer service team provides white-glove support to help ensure your donor testing needs are met with precision and care at every step. 

 

 

Learn more
sales rep speaking with doctor

Scientific contributions at this year's ASRM

We're advancing the conversation in reproductive health through new research. Explore our scientific posters presented at ASRM, showcasing findings that help providers deliver more effective, personalized fertility care.

Monday, October 27, 11:45 AM CST

Exploring possible environmental influences on sperm DNA fragmentation within the United States

Presenter: Samuel Raine, MD, PGY-3, Department of Obsteristics and Gynecology, University of Colorado, Anschutz

Tuesday, October 28, 10:30 AM CST

Added value of 3D genomics-based karyotyping in reproductive patients: A proof-of-concept study​

Presenter: Lauren C. Walters-Sen, PhD, FACMG, Director, Cytogenetics and Genomics, Quest Diagnostics

 

Schedule an appointment with a member of our team at ASRM

Resources

ReproSource is a national leader in specialty fertility diagnostic services. While ReproSource is a Quest Diagnostics affiliate, ReproSource and Quest are separate companies. As such, health plan access, test ordering, and billing processes may differ from those of Quest Diagnostics. Please note that ReproSource is not a Medicare/Medicaid provider. For more information, please contact ReproSource at 1.800.667.8893 or visit ReproSource.com/Contact.

QHerit® 22, QHerit 112, QHerit 198, QHerit 445, and QHerit 611 are carrier screening tests, and they screen for variations in genes linked to certain health disorders that can be passed from parents to children. QHerit 22 screens for 23 genes, QHerit 112 screens for 113 genes, QHerit 198 screens for 199 genes, QHerit 445 screens for 446 genes, and QHerit 611 screens for 612 genes. For a full list of genes that each panel in the QHerit family screens, visit QHerit.com. If the results from any panel in the QHerit family suggest that a patient may be a carrier of a gene variation that can cause a health disorder in her offspring, it is recommended that her reproductive partner be offered genetic screening, and that genetic counseling be provided. Pregnancy management decisions should not be based on the results of these screening tests alone. As with any test, there may be false positives or false negatives. The positive predictive value of the screening test varies by genetic variation, and may be lower for rare conditions. Each panel in the QHerit family is a laboratory-developed test that has been developed and validated pursuant to the Clinical Laboratory Improvements Amendments of 1988 (CLIA) and, as such, it has not been reviewed by FDA.

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.